Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
- LG Chem will spend $17 million to expand capacity at its 20,000-metric-ton plant in Yeosu, South Korea, to 50,000 metric tons. The work is scheduled for completion next year.
- General Electric, Celera Genomics , and Celera Diagnostics will collaborate in research aimed at understanding and differentiating diseases at the molecular level and in developing new treatments. Initially, research projects will support GE's development of novel imaging agents for cancer.
- Morphochem, the German drug discovery firm, has appointed Sijmen de Vries as its new CEO. De Vries formerly was head of global business development and licensing for Novartis Ophthalmics; he has held other posts at Novartis, as well as at SmithKline Beecham and the biotech start-up Rademacher Group.
- Linde has acquired Chevron Texaco's Singapore Syngas operation, which supplies petrochemical makers on Jurong Island. Separately, Linde received permission from the European Commission to sell its refrigeration unit to Carrier for $403 million. Founded in 1879, Linde's first business was ice machines.
- Chiral Quest has entered into a strategic technology agreement with DSM Pharma Chemical. Chiral Quest will license DSM to use its homogenous catalyst system in research screening programs and provide catalytic products and technology to manufacture intermediates. Separately, Sigma-Aldrich agreed to distribute Chiral Quest's Binaphane, C3-TunePhos, TangPhos, and Binapine ligands.
- LPM Technologies, based in St. Nicholas, Quebec, has been acquired by Ciba Specialty Chemicals to boost the latter's pulp and paper chemicals business. LPM has sales running at about $12 million per year in the sectors of retention and drainage, fixatives, water management products, and process chemicals.
Advertisement
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter